Related Experiment Video

Updated: Jul 7, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity

Shumin Zhang1, Katherine Schafer-Hales, Fadlo R Khuri

  • 1Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia 30043, USA.

Cancer Research
|February 5, 2008
PubMed

Insights

Liver kinase B1 (LKB1) is crucial for non-small cell lung cancer (NSCLC) cell polarity. This study reveals LKB1 regulates polarity by interacting with cdc42 and PAK at the cell's leading edge.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • The tumor suppressor Liver kinase B1 (LKB1) is frequently mutated in non-small cell lung cancer (NSCLC).
  • LKB1 is implicated in epithelial cell polarity, but its precise role in cancer cell polarity remains unclear.
  • Understanding LKB1's function is critical for developing targeted therapies for NSCLC.

Purpose of the Study:

  • To investigate the dynamic behavior and function of LKB1 in NSCLC cell polarity.
  • To elucidate the molecular mechanisms by which LKB1 regulates cancer cell polarity.
  • To identify novel pathways involving LKB1 in NSCLC progression.

Main Methods:

  • Live-cell imaging to track LKB1 localization in motile NSCLC cells.
  • LKB1 depletion studies to assess its impact on cell polarity markers.
  • Co-localization and interaction studies with polarity pathway components like cdc42 and PAK.

Main Results:

  • LKB1 is a dynamic, actin-associated protein that rapidly polarizes to the leading edge of motile NSCLC cells.
  • LKB1 depletion causes significant cell polarity defects, including aberrant Golgi positioning and morphology.
  • LKB1 colocalizes with and is required for the proper localization and activation of cdc42 and PAK at the leading edge.

Conclusions:

  • LKB1 is essential for maintaining NSCLC cell polarity.
  • A novel LKB1-cdc42-PAK pathway mediates polarity in lung cancer cells.
  • Targeting this pathway could offer new therapeutic strategies for NSCLC.

More Related Videos

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...